Suppr超能文献

临床营养与药物相互作用。

Clinical nutrition and drug interactions.

作者信息

Ekincioğlu Aygin Bayraktar, Demirkan Kutay

机构信息

Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.

出版信息

Ulus Cerrahi Derg. 2013 Nov 14;29(4):177-86. doi: 10.5152/UCD.2013.112013. eCollection 2013.

Abstract

A drug's plasma level, pharmacological effects or side effects, elimination, physicochemical properties or stability could be changed by interactions of drug-drug or drug-nutrition products in patients who receive enteral or parenteral nutritional support. As a result, patients might experience ineffective outcomes or unexpected effects of therapy (such as drug toxicity, embolism). Stability or incompatibility problems between parenteral nutrition admixtures and drugs might lead to alterations in expected therapeutic responses from drug and/or parenteral nutrition, occlusion in venous catheter or symptoms or mortality due to infusion of composed particles. Compatibilities between parenteral nutrition and drugs are not always guaranteed in clinical practice. Although the list of compatibility or incompatibilities of drugs are published for the use of clinicians in their practices, factors such as composition of parenteral nutrition admixture, drug concentration, contact time in catheter, temperature of the environment and exposure to light could change the status of compatibilities between drugs and nutrition admixtures. There could be substantial clinical changes occurring in the patient's nutritional status and pharmacological effects of drugs due to interactions between enteral nutrition and drugs. Drug toxicity and ineffective nutritional support might occur as a result of those predictable interactions. Although administration of drugs via feeding tube is a complex and problematic route for drug usage, it is possible to minimise the risk of tube occlusion, decreased effects of drug and drug toxicity by using an appropriate technique. Therefore, it is important to consider pharmacological dosage forms of drugs while administering drugs via a feeding tube. In conclusion, since the pharmacists are well-experienced and more knowledgeable professionals in drugs and drug usage compared to other healthcare providers, it is suggested that provision of information and drug counselling by pharmacists in terms of detection and prevention of problems (such as interactions, stability, incompatibility) related with enteral/parenteral nutrition and drugs are invaluable in clinical practice.

摘要

在接受肠内或肠外营养支持的患者中,药物与药物或药物与营养产品之间的相互作用可能会改变药物的血浆水平、药理作用或副作用、消除、理化性质或稳定性。因此,患者可能会出现治疗效果不佳或意外效应(如药物毒性、栓塞)。肠外营养混合液与药物之间的稳定性或不相容性问题可能会导致药物和/或肠外营养的预期治疗反应发生改变、静脉导管堵塞或因输注混合颗粒而出现症状或死亡。在临床实践中,肠外营养与药物之间的相容性并非总能得到保证。尽管已公布药物相容性或不相容性列表供临床医生在实践中使用,但诸如肠外营养混合液的成分、药物浓度、在导管中的接触时间、环境温度和光照等因素可能会改变药物与营养混合液之间的相容性状态。由于肠内营养与药物之间的相互作用,患者的营养状况和药物药理作用可能会发生重大临床变化。这些可预测的相互作用可能会导致药物毒性和营养支持效果不佳。尽管通过饲管给药是一种复杂且存在问题的用药途径,但通过采用适当技术,可以将饲管堵塞、药物效果降低和药物毒性的风险降至最低。因此,通过饲管给药时考虑药物的剂型很重要。总之,由于与其他医疗保健提供者相比,药剂师在药物及用药方面经验更丰富、知识更渊博,建议药剂师在检测和预防与肠内/肠外营养和药物相关的问题(如相互作用、稳定性、不相容性)方面提供信息和药物咨询,这在临床实践中非常宝贵。

相似文献

1
Clinical nutrition and drug interactions.
Ulus Cerrahi Derg. 2013 Nov 14;29(4):177-86. doi: 10.5152/UCD.2013.112013. eCollection 2013.
2
Parenteral nutrition compatibility and stability: Practical considerations.
Nutr Clin Pract. 2024 Oct;39(5):1150-1163. doi: 10.1002/ncp.11189. Epub 2024 Jul 12.
3
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN J Parenter Enteral Nutr. 1999 Mar-Apr;23(2):67-74. doi: 10.1177/014860719902300267.
4
[Polypharmacy and enteral nutrition in patients with complex chronic diseases].
Nutr Hosp. 2017 May 8;34(Suppl 1):57-76. doi: 10.20960/nh.1240.
5
Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice.
Eur J Pharm Sci. 2017 Jan 1;96:449-455. doi: 10.1016/j.ejps.2016.10.015. Epub 2016 Oct 12.
6
Medication administration through enteral feeding tubes.
Am J Health Syst Pharm. 2008 Dec 15;65(24):2347-57. doi: 10.2146/ajhp080155.
7
Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery.
Curr Drug Targets. 2024;25(5):306-329. doi: 10.2174/0113894501284598240226102943.
8
Compounding TPN admixtures: then and now.
JPEN J Parenter Enteral Nutr. 2003 Nov-Dec;27(6):433-8; quiz 439. doi: 10.1177/0148607103027006433.
9
Pharmaceutical Aspects of Artificial Nutrition.
J Clin Med. 2019 Nov 19;8(11):2017. doi: 10.3390/jcm8112017.
10
A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing.
JPEN J Parenter Enteral Nutr. 2014 Mar-Apr;38(3):334-77. doi: 10.1177/0148607114521833. Epub 2014 Feb 14.

引用本文的文献

1
optimization of crushed drug-sensitive antituberculosis medication when administered via a nasogastric tube.
Microbiol Spectr. 2024 Jan 11;12(1):e0287623. doi: 10.1128/spectrum.02876-23. Epub 2023 Nov 22.
2
Consumer's Opinion on a Pharmacist's Role in Nutritional Counseling.
Innov Pharm. 2021 Apr 7;12(2). doi: 10.24926/iip.v12i2.3634. eCollection 2021.
3
Administration of Potential Medications for COVID-19 Treatment Through Feeding Tube.
Turk J Pharm Sci. 2021 Jun 18;18(3):250-251. doi: 10.4274/tjps.galenos.2021.52223.
4
Assessment of drug administration via feeding tube and the knowledge of health-care professionals in a university hospital.
Eur J Clin Nutr. 2017 Feb;71(2):164-168. doi: 10.1038/ejcn.2016.147. Epub 2016 Aug 10.

本文引用的文献

1
Vasoactive substances and their effects on nutrition in the critically ill patient.
Nutr Clin Pract. 2012 Jun;27(3):335-9. doi: 10.1177/0884533612443989. Epub 2012 Apr 13.
2
Safe practices for compounding of parenteral nutrition.
JPEN J Parenter Enteral Nutr. 2012 Mar;36(2 Suppl):14S-19S. doi: 10.1177/0148607111435332.
3
Drug administration through an enteral feeding tube.
Am J Nurs. 2009 Oct;109(10):34-42; quiz 43. doi: 10.1097/01.NAJ.0000361488.45094.28.
5
Vitamin K in parenteral nutrition.
Gastroenterology. 2009 Nov;137(5 Suppl):S105-18. doi: 10.1053/j.gastro.2009.08.046.
6
Recommendations for the use of medications with continuous enteral nutrition.
Am J Health Syst Pharm. 2009 Aug 15;66(16):1458-67. doi: 10.2146/ajhp080632.
8
Enteral nutrition practice recommendations.
JPEN J Parenter Enteral Nutr. 2009 Mar-Apr;33(2):122-67. doi: 10.1177/0148607108330314. Epub 2009 Jan 26.
9
Medication administration through enteral feeding tubes.
Am J Health Syst Pharm. 2008 Dec 15;65(24):2347-57. doi: 10.2146/ajhp080155.
10
Stability and compatibility of histamine H2-receptor antagonists in parenteral nutrition mixtures.
Curr Opin Clin Nutr Metab Care. 2007 May;10(3):311-7. doi: 10.1097/MCO.0b013e3280ebb427.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验